Cause of death, by non-communicable diseases, ages 0-4, female in Malta
Malta: Cause of death, by non-communicable diseases, ages 0-4, female was 50.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Malta, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in Malta stood at 50.2%.
The figure is up 0.9% on the previous year and down 26.2% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Malta peaked at 68.0% in 2010 and was at its lowest, 34.5%, in 2000.
That places Malta 11th out of 185 countries with data for 2021, putting it in the top 10%.
Cause of death, by non-communicable diseases, ages 0-4, female in Malta, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 34.5% | — |
| 2010 | 68.0% | +97.2% |
| 2015 | 48.9% | -28.1% |
| 2019 | 50.4% | +3.1% |
| 2020 | 49.8% | -1.3% |
| 2021 | 50.2% | +0.9% |
Malta compared with similar countries
- Malta's 50.2% is above the median for high income countries, which is 42.8%, 1.2× the median. (58 countries reporting)
- Malta's 50.2% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 35.2%, 1.4× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 34.5% | 34.5% | 34.5% | 1 |
| 2010s | 55.8% | 48.9% | 68.0% | 3 |
| 2020s | 50.0% | 49.8% | 50.2% | 2 |
Countries ranked near Malta
More health data for Malta
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,737 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1693 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0194 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1495 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Malta?
- Cause of death, by non-communicable diseases, ages 0-4, female in Malta was 50.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Malta?
- The highest recorded value was 68.0% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Malta?
- The lowest recorded value was 34.5% in 2000.
- How does Malta rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Malta ranks 11th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Malta?
- Over the last ten years it is down 26.2%. The long-run trend across the full record is rising.
- Where does this Malta data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.